Avro India Limited, one of India’s leading manufacturers of high-quality plastic molded furniture and a significant player in flexible plastic recycling, has reported robust financial results for the second quarter of FY25. The company achieved notable quarter-on-quarter growth, with revenue rising by 8%, EBITDA surging by 36%, and profit after tax (PAT) increasing by 26%. […]
Emmforce Autotech Limited has reported a strong financial and operational performance for the half-year ending September 30, 2024. The company, renowned for its commitment to innovation and strategic investments, showcased remarkable resilience and growth across key metrics, positioning itself for sustained success. Revenue from operations reached ₹3,505.42 lakhs during the period, a figure buoyed by […]
Akums Drugs and Pharmaceuticals Limited, a leading name in the Indian pharmaceutical industry, has announced its unaudited financial results for the first quarter of FY25, showcasing significant growth and strategic advancements. As the largest India-focused Contract Development and Manufacturing Organization (CDMO), Akums has continued to strengthen its market position, particularly in the domestic market where […]
Rajoo Engineers Limited has unveiled impressive financial results for the first quarter ended June 30, 2024, showcasing significant growth and strategic advancements. The company’s latest unaudited consolidated financials reveal a robust performance, driven by increased revenue and substantial profit margins. The announcement highlights key developments, including a major facility expansion and new product launches. Record-Breaking […]
Coforge Limited, listed on the National Stock Exchange of India (NSE) under the ticker COFORGE, reported a substantial increase in its financial performance for the first quarter of FY25. The company’s revenue for the quarter reached INR 24,008 million (approximately US$ 291.4 million), reflecting an 8.1% year-over-year increase in Indian Rupee terms and a 7.2% […]
Adani Portfolio has reported a stellar financial performance for the fiscal year 2024, achieving an unprecedented EBITDA growth of 45%, amounting to USD 10 billion. This significant growth underscores the robustness and resilience of the portfolio’s core infrastructure businesses, which contribute 84% of the total EBITDA, ensuring a highly predictable cash flow generation. The substantial […]
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance across its diversified markets despite some challenges in North America. Glenmark Pharmaceuticals Financial Highlights and Performance For the fourth quarter of FY 2023-24, Glenmark reported a consolidated revenue of Rs. […]